Real Price to Acquire Entire Company: igmbio.com (IGMS)
The share price history of IGM Biosciences, Inc. (IGMS) reflects the dynamics of the enterprise value, which currently stands at . The business focuses on developing IgM-based oncology therapies utilizing a flexible platform that eliminates plant-related capital expenditures. Patents and stringent FDA safety requirements ensure a high barrier to entry. Laboratory stability is maintained through an option system that retains leading clinical trial specialists.
IGM Biosciences (IGMS) - metric breakdowns and financial figures
- price and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Analysis of all company metrics:IGM Biosciences, Inc.
Enterprise Value (EV) combines market capitalization and net debt, determining the actual price for a full buyout of IGM Biosciences, Inc. (IGMS) for a strategic investor. The dynamics of the company's total capital reflect the balance between liquidity burn for IgM antibody R&D and the market valuation of intellectual property, allowing for the separation of speculative stock growth from the real value of the bioengineering platform.
Competitors of IGM Biosciences, Inc. (IGMS)
Full Takeover Company Value argenx N.V.|BNTX - Total Company Value|Abivax Pharma (ABVX) - Real Price to Acquire Entire Company|ADMA Biologics (ADMA) - Total Company Value|PTGX - Company Buyout Price|Total Company Value Immunovant|Kiniksa Pharmaceuticals, Ltd. - Full Business Value|Enterprise Value GRFS|ADPT (Adaptive Biotechnologies Inc.) - Value Adjusted for Debt and Cash|Enterprise Value CLDX (Celldex Therapeutics)|Enterprise Value auriniapharma.com AUPH|BCRX - Total Company Value|Value Adjusted for Debt and Cash VERA (Vera Therapeutics Inc)|Dianthus Pharma (DNTH) - Total Company Value|Real Price to Acquire Entire Company Pharvaris Pharma|ABCL (AbCellera Biologics Inc) - Enterprise Value|Enterprise Value tourmalinebio.com|Real Price to Acquire Entire Company PGEN (Precigen)|PHAR (Pharming Group NV) - Value Adjusted for Debt and Cash|Enterprise Value NKTR (Nektar)|Company Buyout Price Upstream Pharma (UPB)|ZBIO - Total Company Value|immunome.com (IMNM) - Real Price to Acquire Entire Company|Gossamer Bio (GOSS) - Total Company Value|Real Price to Acquire Entire Company KalVista Pharma|Real Price to Acquire Entire Company SEPN|Enterprise Value Pieris Corp|Total Company Value Savara Inc. (SVRA)|rigel.com - Business Value|Enterprise Value ANAB (AnaptysBio)|Astria Therapeutics Inc (ATXS) - Total Enterprise Value|enGene Bio - Enterprise Value|Company Buyout Price RAPT Therapeutics Inc. RAPT|JBIO: Enterprise Value|Full Takeover Company Value aclaristx.com ACRS|Total Company Value Kyverna Therapeutics, Inc.|Real Price to Acquire Entire Company Tiziana Life Sciences Ltd. (TLSA)|Real Price to Acquire Entire Company CABA (Cabaletta Bio, Inc)|VTYX (Ventyx Biosciences, Inc) - Value Adjusted for Debt and Cash|Enterprise Value THTX (Theratechnologies Inc.)|avalotx.com - Total Company Value|Eledon Pharmaceuticals, Inc. - Enterprise Value|Company Buyout Price Agenus, Inc. AGEN|Climb Bio, Inc. (CLYM) - Total Company Value|Total Enterprise Value Zura Bio Ltd (ZURA)|Total Company Value aTyr Pharma, Inc.|Adagene Corp (ADAG) - Company Buyout Price|Enterprise Value IMA|Real Price to Acquire Entire Company shattucklabs.com STTK|Enterprise Value EQ (Equillium)|Company Buyout Price Connect Biopharma Holdings (CNTB)|Immunic Inc - Enterprise Value|Total Enterprise Value Atara Biotherapeutics|inflarx.de (IFRX) - Total Company Value|Business Value XFOR|ACET (Adicet Bio Inc.) - Enterprise Value|Real Price to Acquire Entire Company Celularity Corp (CELU)|Enterprise Value INMB|BRNS - Total Enterprise Value|Total Company Value Kezar Life Sciences, Inc. KZR|Company Buyout Price SAB Biotherapeutics Inc. (SABS)|AKTX: Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash ENLV (Enlivex Therapeutics)|QTTB: Enterprise Value|GOVX - Company Buyout Price|Total Company Value Edesa Biotech|Business Value IBIO (iBio Inc)|Enterprise Value CARM|Real Price to Acquire Entire Company XTL Bio XTLB|Bolt Biotherapeutics, Inc. - Real Price to Acquire Entire Company|Company Buyout Price HCW Biologics, Inc. (HCWB)|Aptevo - Enterprise Value|Company Buyout Price AIM ImmunoTech, Inc. AIM|ADTX: Enterprise Value|Full Takeover Company Value GRI Bio Corporation GRI|Total Company Value XORTX Therapeutics Inc.|Real Price to Acquire Entire Company reshapelifesciences.com (HIND)|Total Company Value Revelation Biosciences, Inc. (REVB)|Company Buyout Price Indaptus Therapeutics Inc|Total Company Value Scinai SCNI|CALI (CalciMedica Inc) - Full Business Value|Affimed Therapeutics - Enterprise Value|Value Adjusted for Debt and Cash ALLK (Allakos Inc.)|HOOK: Enterprise Value|iTeos Therapeutics Inc (ITOS) - Enterprise Value|Total Company Value Ocean Bio|TCBP: Value Adjusted for Debt and Cash|Total Company Value Third Harmonic Bio (THRD)